Satraplatin Uses, Dosage, Side Effects and more
Satraplatin is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.
| Attribute | Details |
|---|---|
| Trade Name | Satraplatin |
| Generic | Satraplatin |
| Satraplatin Other Names | Satraplatin |
| Type | |
| Formula | C10H22Cl2N2O4Pt |
| Weight | Average: 500.283 Monoisotopic: 499.060437065 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in lung cancer, prostate cancer, and solid tumors.
How Satraplatin works
This drug binds to the DNA of cancer cells, inhibiting cell division.
